Literature DB >> 10449603

Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas.

S Thelin-Järnum1, C Lassen, I Panagopoulos, N Mandahl, P Aman.   

Abstract

Myxoid liposarcomas (MLS) carry a t(12;16) or, more rarely, a t(12;22) resulting in fusion of the transcription factor gene CHOP on chromosome 12 with TLS/FUS on chromosome 16 or EWS on chromosome 22. The chimeric TLS-CHOP or EWS-CHOP proteins most probably function as abnormal transcription factors, causing transcriptional de-regulation of several target genes and relaxation of functions critical for growth and differentiation control. A PCR-based subtractive hybridization technique was used to identify genes that are differentially expressed in TLS-CHOP-carrying MLS but not in normal fat tissue. Six myxoid-liposarcoma-associated transcripts, MLAT, were isolated. The genes identified as MLAT can be divided into 2 groups. MLAT1, 2 and 6 show high similarity to glia-derived nexin, neuronatin and the RET oncogene, respectively, all normally involved in development of tissues of neural origin. MLAT3 to MLAT5 represent new genes. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449603     DOI: 10.1002/(sici)1097-0215(19990924)83:1<30::aid-ijc6>3.0.co;2-4

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  23 in total

Review 1.  Subtractive hybridization--genetic takeaways and the search for meaning.

Authors:  R J Byers; J A Hoyland; J Dixon; A J Freemont
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

Review 2.  The TET family of proteins: functions and roles in disease.

Authors:  Adelene Y Tan; James L Manley
Journal:  J Mol Cell Biol       Date:  2009-09-24       Impact factor: 6.216

3.  Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.

Authors:  Marieke A de Graaff; Jamie S E Yu; Hannah C Beird; Davis R Ingram; Theresa Nguyen; Jeffrey Juehui Liu; Svetlana Bolshakov; Károly Szuhai; Pierre Åman; Keila E Torres; Dina Lev; Torsten O Nielsen; Judith V M G Bovée; Alexander J Lazar; Neeta Somaiah
Journal:  Lab Invest       Date:  2016-06-06       Impact factor: 5.662

4.  Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.

Authors:  Mattias K Andersson; Melker Göransson; Anita Olofsson; Carola Andersson; Pierre Aman
Journal:  BMC Cancer       Date:  2010-06-01       Impact factor: 4.430

5.  The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis.

Authors:  Sébastien Bergeron; Etienne Lemieux; Véronique Durand; Sébastien Cagnol; Julie C Carrier; Jacques G Lussier; Marie-Josée Boucher; Nathalie Rivard
Journal:  Mol Cancer       Date:  2010-10-13       Impact factor: 27.401

Review 6.  [Identification of genes over-expressed in myxoid/round cell liposarcoma. DNA microarray analysis and immunohistochemical correlation].

Authors:  C Lanckohr; A Kasprzynski; L Klein-Hitpass; H-H Homann; M Lehnhardt; O Müller; C Kuhnen; P Herter
Journal:  Pathologe       Date:  2010-02       Impact factor: 1.011

7.  Liposarcoma: molecular genetics and therapeutics.

Authors:  Rachel Conyers; Sophie Young; David M Thomas
Journal:  Sarcoma       Date:  2010-12-27

8.  Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and casein kinase II inhibition as a potential treatment option.

Authors:  Stefan M Willems; Yvonne M Schrage; Inge H Briaire-de Bruijn; Karoly Szuhai; Pancras C W Hogendoorn; Judith V M G Bovée
Journal:  Mol Cancer       Date:  2010-09-23       Impact factor: 27.401

9.  Spatiotemporal expression of SERPINE2 in the human placenta and its role in extravillous trophoblast migration and invasion.

Authors:  Schu-Rern Chern; Sheng-Hsiang Li; Chien-Ling Chiu; Hsiao-Ho Chang; Chih-Ping Chen; Edmund I Tsuen Chen
Journal:  Reprod Biol Endocrinol       Date:  2011-08-02       Impact factor: 5.211

10.  Comparative proteomic analysis of proteins involved in the tumorigenic process of seminal vesicle carcinoma in transgenic mice.

Authors:  Wei-Chao Chang; Chuan-Kai Chou; Chih-Chiang Tsou; Sheng-Hsiang Li; Chein-Hung Chen; Yu-Xing Zhuo; Wen-Lian Hsu; Chung-Hsuan Chen
Journal:  Int J Proteomics       Date:  2010-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.